Caxton Corporation’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1K Hold
18,403
0.12% 11
2025
Q1
$11.3K Hold
18,403
0.22% 12
2024
Q4
$19.3K Hold
18,403
0.12% 14
2024
Q3
$36.1K Hold
18,403
0.15% 11
2024
Q2
$36.9K Buy
+18,403
New +$36.9K 0.19% 11